Wilson Sonsini Goodrich & Rosati advised RA Capital Management on the deal. Rivus Pharmaceuticals, a clinical-stage biopharmaceutical company dedicated to improving cardio-metabolic health, announced the completion...
Rivus Pharmaceuticals’ $132 Million Series B Financing
Aadi Bioscience’s $72.5 Million Private Placement Equity Financing
Wilson Sonsini represented Aadi Bioscience, Inc. on the deal. Aadi Bioscience, Inc., a commercial-stage biopharmaceutical company focused on precision therapies for genetically-defined cancers with alterations in...
Ventyx Biosciences’ $176.6 Million Private Placement of Common Stock
Wilson Sonsini Goodrich & Rosati advised Ventyx Biosciences on the deal. Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company focused on advancing novel oral therapies that address...
Phantom Neuro’s $6 Million Seed Funding Round
Wilson Sonsini advised Investor Time BioVentures on the deal. Phantom Neuro, the first-of-its-kind neurotech startup that delivers a low power, high accuracy system for lifelike control...
Redesign Health’s $65 Million Series C Financing
Wilson Sonsini Goodrich & Rosati advised Redesign Health on the deal. Redesign Health, a New York City-based company that builds other healthcare start-ups, closed a $65...
Denim’s $126 Million Series B Round Financing
Wilson Sonsini advised Investor Pelion on the deal. Denim, a leading financial enablement platform for the freight and logistics industry, announced the closing of $126 million,...
Equillium’s Acquisition of Metacrine
Wilson Sonsini advised Metacrine on the deal. Equillium, Inc. and Metacrine Inc. announced that the two companies have entered into a definitive merger agreement pursuant to...
Lunar Energy’s $300 Million Funding Rounds
Wilson Sonsini advised Lunar Energy on the deal. Lunar Energy, a California-based start-up dedicated to delivering home electrification, emerged from stealth mode having successfully raised over...
PolyAI’s $40 Million Series B Financing
Wilson Sonsini Goodrich & Rosati advised PolyAI on the deal. PolyAI, a leading provider of enterprise voice assistants, raised $40 million in a Series B funding...
Think Bioscience’s $17 Million Seed Round
Wilson Sonsini advised Think Bioscience on the deal. Think Bioscience, a synthetic biology company focused on developing small-molecule therapeutics that target difficult-to-drug proteins, announced it has...
Carbon’s Acquisition of ParaMatters
Wilson Sonsini advised Carbon on the deal. Carbon, a leading 3D printing technology company, announced that it has acquired ParaMatters, a software provider for additive manufacturing....
Misfits Market’s Acquisition of Imperfect Foods
Wilson Sonsini advised Misfits Market on the deal. Misfits Market, the online grocery platform driven by accessibility, affordability, and sustainability, announced the acquisition of online grocer...